Literature DB >> 745639

Bacterial populations of the small intestine in uremia.

M L Simenhoff, J J Saukkonen, J F Burke, L G Wesson, R W Schaedler, S J Gordon.   

Abstract

The small intestinal bacterial flora of 15 patients with chronic renal insufficiency was compared with that of subjects with blind loop synDROME. 9 patients were on regular hemodialysis with high protein intake and 6 (serum creatinine 7.5 to 12.5 mg/dl) were maintained on low protein diet. The chronic renal patients harbored a greatly increased microbial flora of both anaerobes and aerobes in the duodenum and jejunum, quantitatively comparable to those in blind loop subjects. The composition did not differ significantly in the two groups. Some organisms may have the potential to metabolize substrates which reach the intestinal lumen from the diet and bile, and perhaps to generate toxic metabolites that could contribute to uremic toxicity or malabsorption.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 745639     DOI: 10.1159/000181424

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  20 in total

Review 1.  Clinical and experimental use of probiotic formulations for management of end-stage renal disease: an update.

Authors:  Alessandro Di Cerbo; Federica Pezzuto; Lucia Palmieri; Valentina Rottigni; Tommaso Iannitti; Beniamino Palmieri
Journal:  Int Urol Nephrol       Date:  2013-04-13       Impact factor: 2.370

Review 2.  The Gut as a Source of Inflammation in Chronic Kidney Disease.

Authors:  Wei Ling Lau; Kamyar Kalantar-Zadeh; Nosratola D Vaziri
Journal:  Nephron       Date:  2015-05-09       Impact factor: 2.847

3.  Chronic renal failure-induced changes in serum and urine bile acid profiles.

Authors:  F Jimenez; M J Monte; M Y El-Mir; M J Pascual; J J G Marin
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

4.  Real-time PCR analysis of the intestinal microbiotas in peritoneal dialysis patients.

Authors:  I-Kuan Wang; Hsueh-Chou Lai; Cheng-Ju Yu; Chih-Chia Liang; Chiz-Tzung Chang; Huey-Liang Kuo; Ya-Fei Yang; Chung-Chih Lin; Hsin-Hung Lin; Yao-Lung Liu; Yi-Chih Chang; Yi-Ying Wu; Chu-Huang Chen; Chi-Yuan Li; Feng-Rong Chuang; Chiu-Ching Huang; Chih-Hsueh Lin; Hung-Chih Lin
Journal:  Appl Environ Microbiol       Date:  2011-12-16       Impact factor: 4.792

5.  Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure.

Authors:  M Magnusson; K E Magnusson; T Sundqvist; T Denneberg
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

Review 6.  Exploring the Microbiome in Heart Failure.

Authors:  Takeshi Kitai; Jennifer Kirsop; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2016-04

Review 7.  Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.

Authors:  Daniel Y Li; W H Wilson Tang
Journal:  Semin Nephrol       Date:  2018-03       Impact factor: 5.299

8.  Effects of an enteric anaerobic bacterial culture supernatant and deoxycholate on intestinal calcium absorption and disaccharidase activity.

Authors:  K Walshe; M J Healy; A B Speekenbrink; C T Keane; D G Weir; R R O'Moore
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

9.  An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients.

Authors:  Carmela Cosola; Maria Teresa Rocchetti; Ighli di Bari; Paola Maria Acquaviva; Valentina Maranzano; Simone Corciulo; Agostino Di Ciaula; Domenica Maria Di Palo; Flavia Maria La Forgia; Sergio Fontana; Maria De Angelis; Piero Portincasa; Loreto Gesualdo
Journal:  Toxins (Basel)       Date:  2021-05-05       Impact factor: 4.546

10.  The consequences of altered microbiota in immune-related chronic kidney disease.

Authors:  Wei Ling Lau; Yongen Chang; Nosratola D Vaziri
Journal:  Nephrol Dial Transplant       Date:  2021-09-27       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.